Innate Pharma SA (IDD.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:15AM CEST
| Previous close | 2.2400 |
| Open | 2.2500 |
| Bid | 2.2350 x N/A |
| Ask | 2.3150 x N/A |
| Day's range | 2.2500 - 2.2500 |
| 52-week range | 2.1500 - 3.4000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 10 May 2024 - 18 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireInnate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
MARSEILLE, France, May 07, 2024--Innate Pharma announces conference call and webcast for Q1 business update
Business WireInnate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
MARSEILLE, France, April 15, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial of SAR443579 / IPH6101 (NCT05086315), evaluating SAR443579 as a monotherapy for the treatment of blood cancers with high unmet needs, including relapsed or refractory acute myeloid leukemia (R/R AML), B-cell acute lymphoblastic leukemia and hig
Business WireInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
MARSEILLE, France, April 15, 2024--Innate Pharma to hold its Annual General Meeting of shareholders on May 23, 2024
© 2024 Yahoo. All rights reserved.